The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
Recruiting · NCT06911710 · Registry updated 2025-04-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, myeloid leukemia, neoplasm, plasma cell myeloma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2025-04-04 | NCT06911710 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hebei Taihe Chunyu Biotechnology Co., Ltd | 14 |
| Tianjin Medical University General Hospital | 80 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| TianJin China. TianJin Medical University General | Tianjin | China | 1 |